03 January 2024
03 January 2024
Significant weight loss was observed in participants receiving ecnoglutide.
Results from the adult study will help Inventprise to initiate Phase II trials for infants and older adults this year.
Following the completion of preclinical studies, US-based GlucoTrack expects to start first-in-human studies with its implantable continuous glucose monitor this year.
The CaRe PC trial will enrol nearly 30 subjects across three dosing cohorts.
The Phase Ib MAD study is a critical step in assessing RGLS8429's safety and tolerability in adult patients with autosomal dominant polycystic kidney disease (ADPKD).
The treatment showed a favourable safety and tolerability profile, without any serious adverse events recorded.
The primary goal is to evaluate the safety and tolerability of AJ201 in individuals with confirmed SBMA.
The trial will evaluate the efficacy and safety of one dose of the ophthalmic solution compared with placebo.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
